Pathological Mechanism‐Inspired Biomimetic Nano‐Senotherapy for Reversing Experimental Atherosclerosis in ApoE −/− Mice
Advanced Science · 2026
DOI: 10.1002/advs.75850 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Yuhan Tian und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy and Food, Key Laboratory of Research and Application of Ethnic Medicine Processing and Preparation on the Qinghai-Tibet Plateau, …. Hauptthemen laut MEDLINE: Atherosclerosis, Biomimetics, Senotherapeutics, Apolipoproteins E. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Sichuan, Sichuan Province Traditional Chinese Medicine Research Project.
Abstract (Originalsprache)
The greatest challenge in atherosclerosis (AS) management lies in achieving lesion reversal, not merely slowing progression. Senescent cell accumulation—driven by continuous generation and apoptotic resistance—perpetuates plaque pathology and obstructs regression. This study addresses the reversal conundrum through a dual‐action strategy: blocking new senescent cell formation while enhancing clearance of existing senescent cells. We developed a ROS‐responsive dimeric prodrug (K 2 A) from the MPO‐inhibitory tripeptide KYC, which co‐assembles with the senolytics Navitoclax into a nano‐Senotherapy (N@K 2 A). Further cloaked with neutrophil membranes from AS mice, the biomimetic N@K 2 A@NEM precisely targets plaques, responds to local ROS, and orchestrates senescent cell formation and removal. This targeted senotherapeutic intervention demonstrates effective reversal of established experimental AS, offering a potential solution to the field's most pressing clinical dilemma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy and Food, Key Laboratory of Research and Application of Ethnic Medicine Processing and Preparation on the Qinghai-Tibet Plateau, Southwest Minzu University, Chengdu, China.
- Department of Pharmacy, Personalized Drug Research and Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic…
- Department of Pharmacy, Sichuan Provincial People's Hospital East Sichuan Hospital & Dazhou First People's Hospital, Dazhou, China.
ORCID-Profile: Shanshan Li, Qixiong Zhang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Sichuan
- Sichuan Province Traditional Chinese Medicine Research Project
- Chengdu Medical Research Project
- Dazhou Science and Technology Project
- Dazhou Traditional Chinese Medicine Research Project
- Youth Innovation Project of Sichuan Medical Association
- Scientific and Technological Innovation Team for Qinghai-Tibetan Plateau Research in Southwest Minzu University
Zitieren
APA
Tian, Y., Yang, Y., Li, Q., Hu, Y., Hu, Q., Ran, S., Zhou, S., Yang, X., Li, S., & Zhang, Q. (2026). Pathological Mechanism‐Inspired Biomimetic Nano‐Senotherapy for Reversing Experimental Atherosclerosis in ApoE −/− Mice. Advanced Science. https://doi.org/10.1002/advs.75850
Vancouver
Tian Y, Yang Y, Li Q, Hu Y, Hu Q, Ran S, et al. Pathological Mechanism‐Inspired Biomimetic Nano‐Senotherapy for Reversing Experimental Atherosclerosis in ApoE −/− Mice. Advanced Science. 2026. doi:10.1002/advs.75850
BibTeX
@article{Tian2026,
author = {Tian, Yuhan and Yang, Yanrui and Li, Qiuyu and Hu, Ying and Hu, Qin and Ran, Shasha and Zhou, Siyu and Yang, Xiujuan and Li, Shanshan and Zhang, Qixiong},
title = {Pathological Mechanism‐Inspired Biomimetic Nano‐Senotherapy for Reversing Experimental Atherosclerosis in ApoE −/− Mice},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.75850}
}
EUVIMED